Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for CV Sciences (CVSI) over the last 13 years, with Q3 2025 value amounting to $40.9 million.

  • CV Sciences' Gains from Investment Securities changed N/A to $40.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.9 million, marking a year-over-year change of. This contributed to the annual value of $26.8 million for FY2024, which is 977.29% up from last year.
  • According to the latest figures from Q3 2025, CV Sciences' Gains from Investment Securities is $40.9 million.
  • Over the past 5 years, CV Sciences' Gains from Investment Securities peaked at $41.7 million during Q1 2025, and registered a low of -$545000.0 during Q4 2022.
  • In the last 5 years, CV Sciences' Gains from Investment Securities had a median value of $4000.0 in 2021 and averaged $10.8 million.
  • Per our database at Business Quant, CV Sciences' Gains from Investment Securities plummeted by 208000.0% in 2022 and then soared by 268470000.0% in 2024.
  • Over the past 5 years, CV Sciences' Gains from Investment Securities (Quarter) stood at -$32000.0 in 2021, then tumbled by 1603.12% to -$545000.0 in 2022, then skyrocketed by 99.27% to -$4000.0 in 2023, then soared by 1325.0% to $49000.0 in 2024, then skyrocketed by 83297.96% to $40.9 million in 2025.
  • Its last three reported values are $40.9 million in Q3 2025, $41.6 million for Q2 2025, and $41.7 million during Q1 2025.